does semaglutide lower triglycerides Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes Assessment of noninferiority of oral

GLP-1 receptor activation exerts profound systemic effects that indirectly benefit hepatic steatosis and MASH through multiple complementary mechanisms

Whether this leads to receptor downregulation or saturation effects over time has not been studied, but the mechanistic logic suggests the combination produces greater GLP-1 axis stimulation than either compound alone

From a mechanistic standpoint, both compounds activate the same GLP-1 and GIP receptors, which means concurrent administration would likely result in receptor saturation at those pathways without proportional additive benefit

March Madness numbers are better than finals numbers, and thats a 40-minute game

Diabetes 59, 16261634